reduce hospital readmissions in both medical and surgical specialties. Despite coordinated efforts from physicians, nurses, pharmacists, and lower-level care providers, many hospitals have struggled to understand and improve upon the factors that underlie high readmission rates. 15 Few studies have examined the rehospitalization of patients after the neurosurgical care of brain malignancy. The purpose of this study was to determine the 30-day readmission rate for patients undergoing the resection of primary brain tumors and to identify which factors predispose certain patient groups to rehospitalization.
Methods

Data Source
The data source for this study was the California Office of Statewide Health Planning & Development (OSH-PD) longitudinal inpatient-discharge administrative database for the years 1995 to 2010, obtained from the State of California OSHPD (http://www.oshpd.ca.gov/HID/ Products/PatDischargeData/PublicDataSet/). The California inpatient discharge database is an administrative, longitudinal database that represents a 100% sample of all inpatient discharges from California licensed hospitals. Each patient within the database is given a unique, masked patient identifier so that each patient may be followed throughout multiple inpatient hospital stays, across multiple institutions, and over multiple years within the state of California during the study period.
Inclusion and Exclusion Criteria and Definition of End Points
An index admission for surgical treatment of a primary brain tumor was defined using a combination of ICD-9-CM diagnosis and procedure codes. Patients were included in this study if they were given both a diagnosis of supratentorial malignant brain tumor (191.0-191.5, 191.8, 198.9) while also receiving a procedure code for lobectomy (01.53), excision or destruction of tissue or lesion of brain (01.59), or open brain biopsy (01.14) during the same hospital stay. 2, 4 Patients who received a previous craniotomy for any diagnosis prior to their index craniotomy for supratentorial malignant brain tumor were excluded from this study. The primary end point examined in this study was an unplanned hospital readmission less than or equal to 30 days after inpatient discharge for surgical treatment of a primary brain tumor. Within the OSHPD longitudinal inpatient-discharge administrative database, unplanned hospital readmissions are defined as inpatient stays that are unscheduled at the hospital 24 hours prior to patient admission (http://www.oshpd.ca.gov/HID/Products/PatDischarge Data/PublicDataSet/). Planned rehospitalizations were ex cluded from our analysis of readmission. Patients who were discharged to a location other than home after surgery or readmitted to the hospital from a location other than home were not included in our readmission analysis so as to eliminate the effect of inter-and/or intrahospital transfer on 30-day readmissions. However, all patients undergoing an index admission regardless of discharge location were included in our analysis of index surgical episode outcomes (Table 1) .
Patient Characteristics
Patient age, self-declared race/ethnicity, sex, expected primary payer (Medicare, Medi-Cal, private insurance, or uninsured), admission source (home, residential care facility, jail/prison, and others), type of admission (elective or nonelective), discharge disposition (home, died, residential care facility, jail/prison, and others), and calendar year were coded in the California inpatient discharge database. Due to a small sample size of certain ethnic groups within the database, patients of Native American race/ethnicity were combined with "other" race/ethnicity to avoid unstable coefficients in the multivariate model. To assess the effect of general medical comorbidities, the Charlson comorbidity index was calculated for each patient using the method described by Romano and colleagues. 17 The medical history for each patient was defined using ICD-9-CM diagnosis and procedure codes. A patient was determined to have a specific condition if he or she carried a specified ICD-9-CM code on the index surgical admission or during any inpatient episode prior to the index surgical admission episode from 1995 to 2010 (Table 2) .
Hospital Characteristics
Hospital identifier, county location of each hospital, and total charges for each inpatient episode were coded within the California inpatient discharge database. The teaching status of each hospital was determined according to whether the hospital was affiliated with a neurosurgical residency training program (http://www.societyns. org/match_information.html). Pediatric hospitals were defined as those hospitals solely dedicated to the treatment of pediatric patients.
Reasons for 30-Day Readmission
To identify the reasons for readmission, a cross-sectional analysis of ICD-9-CM principal diagnosis codes present on readmission was conducted for all patients readmitted within 30 days of discharge. Each ICD-9-CM principal diagnosis code with more than 1% prevalence in readmitted patients was placed into 1 of 15 disease categories ( Table 2 ). The ICD-9-CM codes comprising each of the 15 disease categories were used to tabulate the number of readmitted patients who belonged in each disease category. Because of the longitudinal nature of the data used in this study, we were able to determine which diagnoses were present on both discharge and readmission for each patient. We established the reason for each patient's readmission as a diagnosis that was not present on discharge but was present as a primary diagnosis on readmission.
Statistical Analysis
Bivariate analysis of mean patient age, surgical length of stay (LOS), Charlson score, and readmission status was performed using the Welch t-test. Bivariate analysis of patient factors and readmission status was performed using the Pearson chi-square test. Multivariate analyses were performed using logistic regression models to determine the odds of hospital readmission within 30 days of surgical discharge while adjusting for age, demographics, surgical admission LOS, race/ethnicity, sex, expected primary payer, hospital teaching status, California county, calendar year of surgery, medical history prior to surgical admission, and complications arising during surgical admission.
Expected 30-day readmission rates were calculated for each patient using a multivariate logistic regression model for 30-day readmission. The expected likelihoods of 30-day readmission were then aggregated by hospital, and the ratio of observed to expected readmissions for each hospital was calculated. Statistical analysis was performed using commercially available software (STATA/ AMP 10, Stata Corp. LP). All tests were 2-sided, and p values < 0.05 were considered statistically significant.
Results
There were 18,506 inpatient admissions for resection of primary brain tumors in California between 1995 and 2010. Four hundred ten patients (2.2%) died during the index surgical admission, 13,586 patients (73.4%) were discharged home, and 4510 patients (24.4%) were transferred to another facility (Table 1) .
Among the home discharge patients, 1790 (13.2%) had at least 1 unplanned readmission within 30 days of discharge, and 483 (27%) of these readmitted patients were readmitted to a different hospital than the hospital from which they were discharged following the index surgical episode (Table 3 ). There were also 377 patients excluded from our analysis who had a planned readmission within 30 days of discharge. A majority of these planned readmissions were for brain excision (28.6%), chemotherapy (22.0%), and radiotherapy (9.3%).
Index Admission Episodes
The median age of patients undergoing tumor resection was 54 years. The majority of patients were privately insured non-Hispanic white patients who received neurosurgical care at nonacademic medical centers ( Table  1 ). The median LOS for index surgical admission was 6 days, and the median total charges per index surgical admission were $72,029 ( Table 1 ). The most prevalent diseases in patients' medical histories prior to surgery were hypertension (32.4%), tobacco use disorder (19.0%), and seizure and convulsive disorder (13.2%).
Thirty-Day Outcomes and 30-Day Readmissions
Three hundred sixteen patients (2.3%) died within 30 days of home discharge (Table 3 ). A total of 1790 patients were rehospitalized within 30 days of discharge, and the median time to first readmission was 11 days. Although a majority of readmitted patients had only 1 readmission episode, 11.8% of readmitted patients had multiple read- missions and there were a total of 2022 30-day readmission episodes. The median LOS during a readmission was 4 days, and the median hospital charges per 30-day readmission episode were $20,296. The diagnoses that were most often established as reasons of readmission were seizure and convulsive disorder (20.9%), surgical infection of the CNS (14.5%), and motor deficit (12.8%).
Differences Between Readmitted and Nonreadmitted Patients
Patients readmitted within 30 days had a 2-day longer median LOS on their index surgical episode than nonreadmitted patients. There were significant racial/ethnic differences noted between the 2 groups. Readmitted patients were more frequently African American or Hispanic than nonreadmitted patients. Patients with at least one 30-day hospital readmission were more often Medicare and Medi-Cal beneficiaries and less often privately insured. Other observed differences between readmitted and nonreadmitted patients are noted in Table 4 .
The results of the multivariate analyses are presented in Table 5 . In the multivariate regression model, longer LOSs were associated with greater odds of subsequent readmission. Medi-Cal beneficiaries were at an increased likelihood of readmission relative to the privately insured (OR 1.52, 95% CI 1.20-1.93) as were patients with histories of prior myocardial infarctions (OR 1.64, 95% CI 1.06-2.54). The development of hydrocephalus during the index surgical admission was associated with a higher likelihood of 30-day readmission (OR 1.58, 95% CI 1.20-2.07) as was the development of a deep venous thrombosis (DVT), pulmonary embolism (PE), or other venous complication (OR 3.88, 95% CI 1.84-8.18). Urinary tract infections during the index surgical episode were associated with lower odds of 30-day readmission (OR 0.52, 95% CI 0.29-0.94).
Readmission Rates by Hospital
Forty hospitals (20.7%) had higher than expected 30-day readmission rates after craniotomy for resection of primary malignant brain tumors during the study period (Fig. 1) . Among patients discharged home during the study period, 501 craniotomies were performed at a pediatric hospital within California and 133 (26.6%) of these patients had at least one 30-day readmission, while 13,085 craniotomies were performed at a nonpediatric hospital and 1657 (12.7%) of these patients had at least 1 readmission. Additionally, among home-discharged patients, 8885 craniotomies were performed at nonteaching hospitals with a readmission rate of 13.3%, while 4701 craniotomies were performed at teaching hospitals with a readmission rate of 12.9%.
Discussion
Neurosurgical Cost Burden of 30-Day Readmission
In this study it was found that 13.2% of all patients discharged home after craniotomy for tumor resection were rehospitalized within 30 days of discharge. Each readmission represented an additional $20,296 in median hospital charges on top of the $72,029 in charges for the index neurosurgical admission. While it is expected that a small fraction of all operative patients will be rehospitalized due to the new onset of unpreventable medical conditions following any surgical procedure, reducing the number of preventable unplanned 30-day readmissions could create significant cost savings for health care payers. It was determined that a 40% reduction in the number of 30-day readmission episodes for brain tumor patients undergoing craniotomy within the state of California would eliminate 606 hospitalizations and create more than $12 million in cost savings. Lowering readmission rates could also create cost savings by preventing redundant medical charges. In this study, it was observed that 27.0% of readmitted patients were rehospitalized at a different location than the site that provided initial surgical care. Because providers within different hospital systems typically operate in isolation from one another, it is reasonable to expect that the care of these readmitted patients included significant unnecessary health care costs in the form of redundant imaging, workup, and care.
In spite of the significant cost and morbidity burden that 30-day readmission places on patients, payers, and providers, it is important to note that most surgical centers in California have observed readmission rates similar to those expected by multivariate modeling. In the present study, it was shown that 20.7% of hospitals had an observed to expected ratio of 30-day readmission rates that was significantly greater than 1. This implies that almost 80% of the hospitals in California performing craniotomy for tumor resection operated at an expected level of care quality during the study period, and only one-fifth of hospitals would be financially penalized in the future according to Centers for Medicare & Medicaid Studies guidelines for 30-day readmission. 3 While the scope of this study focused on patient-level factors, it is believed that future investigation into specific hospital-level factors associated with higher than expected readmission rates is warranted.
Predictors of Readmission
Many studies in the surgical literature regarding 30-day readmissions establish postoperative complications as a common risk factor for readmission across multiple specialties. 5, 6, 8, 11, 16 The present study similarly showed that certain complications arising during the index surgical admission increase the odds of readmission for patients after the resection of brain malignancy. Specifically, patients who developed hydrocephalus during the surgical admission had 58% greater odds of readmission than those who did not develop hydrocephalus. Furthermore, patients who experienced a DVT, PE, or venous complication during surgical admission were nearly 4 times more likely to be readmitted within 30 days of discharge. It is thus proposed that more astute monitoring and management of both hydrocephalus and venous complications in the perioperative period may reduce the frequency of 30-day patient rehospitalizations.
Previous studies have found that longer LOSs during surgical hospitalization are associated with an increased risk of readmission, with the assertion being that LOS serves as a surrogate for postoperative complications. 11, 18 The results of the present study showed a similar trend of increasing odds of readmission for LOSs greater than 1 week. We propose that longer LOSs are inherently associated with a greater level of postoperative complications and greater risk of acquiring nosocomial infections, which may increase the risk of readmission.
Certain components of a patient's medical history were also shown to be associated with readmission. While other studies have shown an association between comorbidities and readmission, these studies have focused solely on comorbidities present at admission as a predictor of readmission. The present study, in contrast, used a longitudinal database and was able to characterize the presence of pathologies throughout the portion of a patient's medical history occurring during the study period rather than being limited to those pathologies present on initial surgical admission. Patients who had any history of myocardial infarction were observed to have a 64% greater likelihood of 30-day readmission than those patients without a history of myocardial infarction. This is the first study (to our knowledge) that examined patients' medical histories rather than comorbidities present on admission, and we propose that additional investigation be undertaken to better understand the relationship between medical history and readmission. Lastly, it was found that Medi-Cal beneficiaries had increased odds for readmission relative to privately insured patients (OR = 1.52). Initially, it was believed that perhaps Medi-Cal patients were at increased odds of readmission because of premature discharge after surgery. However, on further analysis it was shown that the median LOS during surgical admission was 4 days for privately insured patients and 8 days for Medi-Cal beneficiaries. As a result, it is proposed that certain factors within the population of Medi-Cal patients predispose them to longer LOSs and greater odds of rehospitalization. We believe that a randomized clinical trial is necessary to better understand the factors that increase the likelihood of readmission among Medi-Cal patients. The results of such future studies could prove to be essential to our understanding of 30-day readmissions in neurosurgery. Additionally, it is possible that there may be differences in both the surgical technologies used and the index surgical procedures performed on Medi-Cal beneficiaries versus privately insured patients that increase the likelihood of readmission in the Medi-Cal group. Early application of technologies such as intraoperative MRI, image-guided surgery platforms, and cranial tractography may create Table 5 are patient age, California county, and calendar year. † Values in bold are statistically significant.
Fig. 1.
Observed/expected 30-day readmission rates by hospital. The triangles represent each California (CA) hospital's observed readmission rate divided by the expected readmission rate for that hospital as calculated from our multivariate model of readmissions. A hospital that has an observed rate equal to the predicted/expected rate has a triangle at 1 (red line). The error bars represent the 95% CI around each triangle. Forty (20.7%) of 193 hospitals had observed/expected 30-day readmission rates that were significantly greater than 1 (p ≤ 0.05). differences in neurooncological care based on patient insurance status. The current population-based study, however, is unable to resolve the differences that may exist in the types of procedures performed between insurance groups. We hope that future investigations will better detail the disparities in surgical care provided to Medi-Cal beneficiaries compared with their privately insured counterparts.
Clinical Applications
A better understanding of the factors that influence the likelihood of readmission for neurosurgical patients will allow providers to institute programs for reducing 30-day readmissions. Previous studies have begun to define the types of systematized action that hospitals may take to reduce readmission rates, and we believe that the results of the present study highlight potential interventions that require further investigation.
Because the two most common diagnoses present on readmission were seizure and CNS infection, we suggest that better and more aggressive seizure prophylaxis and antibiotic regimens could potentially reduce readmission rates after the resection of brain malignancy. Furthermore, there is evidence to suggest that better patient education and medication counseling as part of a discharge bundle approach decreases unplanned acute care utilization at 30 days.
9,12 A discharge bundle for neurosurgical patients after tumor resection could include education about the symptoms of surgical site infection and seizure disorder that warrant a return to the clinic. This intervention would allow early identification and treatment of developing postoperative morbidity in an outpatient setting rather than through inpatient readmission. A neurosurgical discharge bundle could also include patient counseling from a clinical pharmacist about correct dosing schedules and durations of pharmacotherapies. While the time and resources required for the implementation of this discharge bundle approach may not be feasible for all patients, the patient groups at risk for readmission highlighted in this study may benefit from this intervention.
Postdischarge interventions directed at these highrisk patient groups could also prove to be of benefit in reducing 30-day readmissions. 7 The Agency for Healthcare Research and Quality has established timely followup appointment scheduling as an important component of the discharge workflow that may reduce readmission. The time course for scheduling follow-up appointments in current neurosurgical practice varies between institutions; however, the results of this study establish 11 days as the median time to 30-day readmission. Implicit in this finding is that half of all readmissions will occur after 11 days postdischarge, and we believe that this is an important time point for surgeons to identify patients with developing pathologies that have the potential to cause rehospitalization.
Strengths and Limitations
This is the first investigation to analyze 30-day readmissions in neurosurgical practice, and it is important to address both the strengths and the limitations in the present study. First, analyses that use large administrative databases rely on the use of ICD-9 diagnosis codes to identify patients and their outcomes. These ICD-9 diagnosis codes are used for hospital billing, and lack clinical data such as histological grades, radiological diagnoses, and physiological parameters. As a consequence, the current study was not able to investigate the epidemiology of readmission for specific types of intracranial malignancy. Nevertheless, we believe that this investigation represents an important step toward a better macro understanding of the readmission process following craniotomy for intracranial malignancy. We expect that future studies will be more granular (that is, specifically tailored to each unique tumor classification) by drawing upon the conclusions of this report to better elucidate the differences in readmission between distinct classifications of brain tumors.
Second, ICD-9 diagnosis coding is often performed by lower level clinical professionals rather than by experienced clinicians and surgeons. As such, inaccuracies in diagnostic and procedural coding may be introduced to the data set. While the use of ICD-9 coding may be associated with potential inaccuracies, it is unlikely that these inaccuracies would be biased or systematic in a manner that would affect our conclusions. Instead, the use of administrative data in this study increased the statistical power of our analysis by allowing for a more robust sample size and a reduction in Type II errors.
Third, unlike a prospective study, the nature and processes related to readmission are inferred. We took several steps to clarify the types of patients being studied in this report. First, we focused on patients who were discharged home. While there are likely preventable readmissions in patients who are discharged to rehabilitation or nursing facilities, we wished to focus on patients who had achieved the best initial outcomes following craniotomy and were discharged home. We also sought to avoid potentially confounding effects of patients who were transferred from one facility to another facility for a higher level of care in this report. We plan to report on patterns of transfer of care in a future report. Second, we chose to analyze readmission episodes that were unplanned. In some patients, a practice pattern of biopsy followed by readmission for definitive craniotomy may be performed. As a result, we excluded all planned readmissions from our analysis to avoid characterizing this practice pattern as a preventable 30-day readmission. Our exclusion of planned readmissions is also in accordance with the Centers for Medicare and Medicaid Services recommendations for defining preventable readmission. not be effective surrogates for true readmission rates. 13 The use of a longitudinal data set that follows each patient across multiple hospitals and across multiple years allowed us to avoid the underestimation of true readmission rates noted in other studies.
Conclusions
In this report, we determined the current 30-day readmission rate in patients undergoing brain tumor surgery who were discharged home in California. Certain medical conditions that are highly prevalent on readmission such as seizure may highlight the need for targeted interventions to improve patient education and therapy surrounding seizure prevention. In addition, this work lays the foundational design for targeted prospective studies of readmission and targeted interventions to reduce 30-day readmission. We also demonstrated the potential cost savings associated with reduction in readmission rates following brain tumor surgery.
